本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

IGM Biosciences

1.27
-0.0100-0.78%
盘后1.26-0.0067-0.53%16:52 EDT
成交量:10.88万
成交额:13.88万
市值:7,644.02万
市盈率:-0.39
高:1.29
开:1.29
低:1.27
收:1.28
数据加载中...
2021/05/06

重要事件披露

8-K - Current report
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/30

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/28

重要事件披露

8-K - Current report
2021/01/13

重要事件披露

8-K - Current report
2021/01/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/09

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/05

重要事件披露

8-K - Current report
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans